Articles & Issues
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received March 4, 2004
Accepted March 31, 2004
- This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.
All issues
Preparation and Characterization of Paclitaxel from Plant Cell Culture
Samyang Genex Biotech Research Institute, Daejeon 305-348, Korea 1Samyang Central R&D Institute, Daejeon 305-348, Korea 2Department of Chemical Engineering, Kongju National University, 182 Shinkwan-Dong, Kongju 314-701, Korea
Korean Journal of Chemical Engineering, July 2004, 21(4), 816-820(5), 10.1007/BF02705526
Download PDF
Abstract
The solvent treatment of paclitaxel is a convenient method for controlling the morphologies of paclitaxel. Amorphous paclitaxel was simply made by dissolving paclitaxel in methylene chloride/methanol (98/2, v/v) and in relatively non-polar solvents (t-butyl methyl ether, pentane, acetonitrile/hexane (1/2, v/v), methylene chloride, chloroform). On the other hand, dihydrated paclitaxel (paclitaxel·2H2O) was made by dissolving paclitaxel in a special polar solvent containing a small amount of water. However, when we used only methanol, we got mixed morphologies of paclitaxel made of both the dihydrated and amorphous forms. Their physicochemical properties were investigated by X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and thermo gravimetric analysis (TGA). The initial water content of amorphous paclitaxel and dihydrated paclitaxel was determined for 0.65 wt% and 5.85 wt%, respectively. The hygroscopic property of dihydrated paclitaxel was very changeable in all given humidity (15, 60, 95 RH%) during storage. Dissolution profiles for paclitaxel showed that amorphous paclitaxel measured the highest solubility in water and its solubility held most stable during the measurements. The residual solvent could be reduced to the maximum allowed value (600 ppm for methylene chloride, 3,000 ppm for methanol) of guidance for the International Conference on Harmonization (ICH) by spray drying.
Keywords
References
Angell CA, Monnerie L, Torell LM, Mater. Res. Soc. Symp. Proc., 215, 3 (1991)
Chiou WL, Riegelman S, J. Pharm. Sci., 60, 1281 (1971)
Choi HK, Yun JH, Kim SI, Son JS, Kim HR, Kim JH, Choi HJ, Hong SS, Enzyme Microb. Technol., 29(10), 583 (2001)
Gi US, Min B, Hong SS, Lee HS, Kim JH, Agric. Chem. Biotech., 43, 176 (2000)
Hancock BC, Shamblin SL, Zografi G, Pharm. Res., 12, 799 (1995)
ICH Guidance Q3C impurities: Residual Solvents, Federal Register, 62(247), 67378 (1997)
Kim JH, Hong SS, Korean J. Biotechnol. Bioeng., 15, 346 (2000)
Kim JH, Choi HK, Hong SS, Lee HS, J. Microbiol. Biotechnol., 11, 204 (2002)
Kim JH, Kang IS, Choi HK, Hong SS, Lee HS, Process Biochem., 37, 679 (2002)
Kwon IC, Yoo YJ, Lee JH, Hyun JO, Process Biochem., 33(7), 701 (1998)
Liggins RT, Hunter WL, Burt HM, J. Pharm. Sci., 86, 1458 (1997)
Martin A, Swarbrick J, Cammarata A, "Physical Pharmacy," Lea and Febiger, Philadelphia (1983)
Mathew AE, Mejillano MR, Nath JP, Himes RH, Stella VJ, J. Med. Chem., 35, 145 (1992)
Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud J, Couladouros EA, Paulvannan K, Sorensen EJ, Nature, 367, 640 (1994)
Sharma US, Baulausbramanaian SV, Straubinger RM, J. Pharm. Sci., 84, 1223 (1995)
Wani Mc, Taylor HL, Wall ME, Coggon P, Mcphail AT, J. Am. Chem. Soc., 93, 2325 (1971)
Chiou WL, Riegelman S, J. Pharm. Sci., 60, 1281 (1971)
Choi HK, Yun JH, Kim SI, Son JS, Kim HR, Kim JH, Choi HJ, Hong SS, Enzyme Microb. Technol., 29(10), 583 (2001)
Gi US, Min B, Hong SS, Lee HS, Kim JH, Agric. Chem. Biotech., 43, 176 (2000)
Hancock BC, Shamblin SL, Zografi G, Pharm. Res., 12, 799 (1995)
ICH Guidance Q3C impurities: Residual Solvents, Federal Register, 62(247), 67378 (1997)
Kim JH, Hong SS, Korean J. Biotechnol. Bioeng., 15, 346 (2000)
Kim JH, Choi HK, Hong SS, Lee HS, J. Microbiol. Biotechnol., 11, 204 (2002)
Kim JH, Kang IS, Choi HK, Hong SS, Lee HS, Process Biochem., 37, 679 (2002)
Kwon IC, Yoo YJ, Lee JH, Hyun JO, Process Biochem., 33(7), 701 (1998)
Liggins RT, Hunter WL, Burt HM, J. Pharm. Sci., 86, 1458 (1997)
Martin A, Swarbrick J, Cammarata A, "Physical Pharmacy," Lea and Febiger, Philadelphia (1983)
Mathew AE, Mejillano MR, Nath JP, Himes RH, Stella VJ, J. Med. Chem., 35, 145 (1992)
Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud J, Couladouros EA, Paulvannan K, Sorensen EJ, Nature, 367, 640 (1994)
Sharma US, Baulausbramanaian SV, Straubinger RM, J. Pharm. Sci., 84, 1223 (1995)
Wani Mc, Taylor HL, Wall ME, Coggon P, Mcphail AT, J. Am. Chem. Soc., 93, 2325 (1971)